COM:INTERCEPTPHARMA
Intercept Pharmaceuticals
- Stock
Last Close
18.96
07/11 21:00
Market Cap
794.69M
Beta: -
Volume Today
3.91M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -67.79M - | -283.23M 317.78% | -226.43M 20.05% | -412.83M 82.32% | -360.37M 12.71% | -309.24M 14.19% | -344.68M 11.46% | -274.88M 20.25% | -91.43M 66.74% | -174.86M 91.26% | |
depreciation and amortization | 105.68K - | 442.80K 318.99% | 1.69M 281.89% | 3.83M 126.55% | 4.60M 20.10% | 4.58M 0.41% | 3.66M 20.06% | 3.12M 14.88% | 2.98M 4.49% | 592K 80.12% | |
deferred income tax | 4.99M - | 4.43M 11.19% | 1.31M 70.51% | 2.38M 82.24% | 4.24M 78.19% | -11.78M 377.67% | |||||
stock based compensation | 9.45M - | 20.13M 113.07% | 34.19M 69.87% | 46.20M 35.15% | 56.97M 23.29% | 49.91M 12.38% | 55.98M 12.16% | 60.85M 8.70% | 33.89M 44.31% | 21.89M 35.41% | |
change in working capital | 178.28K - | 699.01K 292.10% | 21.34M 2,953.60% | 8.44M 60.46% | 14.65M 73.55% | -2.85M 119.44% | 19.33M 779.00% | 2.00M 89.66% | -14.42M 821.21% | 21.92M 252.02% | |
accounts receivables | -9.13M - | -7.38M 19.19% | -9.19M 24.65% | -12.35M 34.34% | -2.65M 78.57% | -7.14M 169.88% | 1.48M 120.71% | ||||
inventory | -2.28M - | -1.20M 47.30% | -3.63M 202.08% | -1.35M 62.68% | -269K 80.13% | 231K 185.87% | 602K 160.61% | ||||
accounts payables | 3.51M - | 6.20M 76.43% | 32.22M 419.67% | 19.96M 38.05% | 29.23M 46.42% | 10.33M 64.65% | 56.41M 445.98% | 13.86M 75.43% | -4.83M 134.80% | 23.29M 582.65% | |
other working capital | -3.34M - | -5.50M 64.90% | -10.87M 97.67% | -116K 98.93% | -6.00M 5,075.86% | -358K 94.04% | -23.38M 6,429.61% | -8.95M 61.72% | -2.68M 70.03% | -3.45M 28.71% | |
other non cash items | 30.06M - | 174.22M 479.65% | 6.30M 96.38% | 11.91M 89.05% | 18.75M 57.38% | 15.57M 16.94% | 26.71M 71.53% | 34.65M 29.70% | 39.11M 12.90% | 103.68M 165.07% | |
net cash provided by operating activities | -28.01M - | -87.74M 213.28% | -162.90M 85.67% | -342.44M 110.21% | -265.40M 22.50% | -240.71M 9.30% | -236.61M 1.70% | -170.03M 28.14% | -41.64M 75.51% | -26.78M 35.69% | |
investments in property plant and equipment | -1.63M - | -4.64M 185.01% | -5.93M 27.82% | -5.08M 14.42% | -10.39M 104.61% | -167K 98.39% | -1.14M 580.24% | -3.89M 242.52% | -397K 89.80% | -568K 43.07% | |
acquisitions net | 187.85M - | -166.71M 188.74% | -71.12M 57.34% | ||||||||
purchases of investments | -125.83M - | -204.34M 62.40% | -640.71M 213.54% | -511.52M 20.16% | -231.11M 54.82% | -436.07M 88.69% | -603.01M 38.28% | -330.71M 45.16% | -349.46M 5.67% | -552.74M 58.17% | |
sales maturities of investments | 57.24M - | 112.40M 96.37% | 257.17M 128.80% | 456.46M 77.49% | 529.27M 15.95% | 388.17M 26.66% | 415.16M 6.95% | 497.42M 19.81% | 420.58M 15.45% | 451.92M 7.45% | |
other investing activites | -187.85M - | 166.71M 188.74% | 71.12M 57.34% | 363.23M 410.71% | |||||||
net cash used for investing activites | -70.21M - | -96.59M 37.56% | -389.47M 303.24% | -60.13M 84.56% | 287.77M 578.55% | -48.07M 116.70% | -188.99M 293.15% | 162.82M 186.15% | 70.73M 56.56% | 261.85M 270.23% | |
debt repayment | -38.13M - | -268.41M 603.95% | |||||||||
common stock issued | 61.17M - | 183.48M 199.95% | 558.76M 204.54% | 261.36M - | 227.26M 13.05% | ||||||
common stock repurchased | -2.16M - | -1.99M 7.60% | -75.83M 3,702.66% | -557K 99.27% | |||||||
dividends paid | |||||||||||
other financing activites | 4.90M - | 7.51M 53.16% | 6.71M 10.59% | 414.38M 6,072.83% | 2.18M - | 232.42M 10,546.68% | 1.30M 99.44% | 115.07M 8,744.89% | 1.65M 98.57% | ||
net cash used provided by financing activities | 66.07M - | 190.98M 189.06% | 565.47M 196.08% | 414.38M 26.72% | 2.84M 99.32% | 263.55M 9,186.29% | 457.52M 73.60% | -693K 100.15% | 1.12M 261.33% | -267.32M 24,010.20% | |
effect of forex changes on cash | -376K - | -873K 132.18% | 1.13M 229.10% | -1.53M 235.40% | -386K 74.71% | -1.22M 217.10% | -1.45M 18.46% | -6.30M 334.62% | |||
net change in cash | -32.15M - | 6.66M 120.72% | 12.72M 90.98% | 10.93M 14.04% | 26.34M 140.90% | -26.77M 201.62% | 31.53M 217.81% | -9.13M 128.94% | 28.75M 415.09% | -38.55M 234.06% | |
cash at beginning of period | 45.51M - | 13.36M 70.64% | 20.02M 49.84% | 32.74M 63.52% | 43.67M 33.39% | 70.01M 60.30% | 43.25M 38.23% | 74.78M 72.91% | 65.65M 12.20% | 94.41M 43.80% | |
cash at end of period | 13.36M - | 20.02M 49.84% | 32.74M 63.52% | 43.67M 33.39% | 70.01M 60.30% | 43.25M 38.23% | 74.78M 72.91% | 65.65M 12.20% | 94.41M 43.80% | 55.86M 40.83% | |
operating cash flow | -28.01M - | -87.74M 213.28% | -162.90M 85.67% | -342.44M 110.21% | -265.40M 22.50% | -240.71M 9.30% | -236.61M 1.70% | -170.03M 28.14% | -41.64M 75.51% | -26.78M 35.69% | |
capital expenditure | -1.63M - | -4.64M 185.01% | -5.93M 27.82% | -5.08M 14.42% | -10.39M 104.61% | -167K 98.39% | -1.14M 580.24% | -3.89M 242.52% | -397K 89.80% | -568K 43.07% | |
free cash flow | -29.64M - | -92.38M 211.73% | -168.84M 82.76% | -347.52M 105.83% | -275.79M 20.64% | -240.88M 12.66% | -237.75M 1.30% | -173.92M 26.85% | -42.04M 75.83% | -27.35M 34.94% |
All numbers in USD (except ratios and percentages)